Abstract:OBJECTIVE
To determine what factors increase the risk of early wound complications in patients undergoing direct anterior total hip arthroplasty whose wounds were closed with 2-octyl cyanoacrylate with mesh.
METHODS
This study was a retrospective review of 75 consecutive patients who underwent direct anterior total hip arthroplasty closed with 2-octyl cyanoacrylate with mesh.
MAIN RESULTS
Of 29 patients who … Show more
“…FORI (Shoulder) [ 153 , 182 , 183 , 424 , 526 , 566 , 567 , 604 ] 2. Texas Southwestern University [ 211 , 459 ] Virginia OrthoVirginia [ 287 , 547 ] ABJHI Alberta Bone and Joint Health Institute, CHKR Center for Hip and Knee Replacement Joint Registry, CJRI Connecticut Joint Replacement Institute, CJRR California Joint Replacement Registry, FOI Florida Orthopaedic Institute, Shoulder, FORI Fondren Orthopedic Research Institute, H&K Hip and Knee, HS Hospital, JAR Joint Arthroplasty Registry, JRR Joint Replacement Registry, MARCQI Michigan Collaborative Quality Initiative, NY New York, RG Registry, OJRR Ontario Joint Replacement Registry, PAR Partners Massachusetts Registry, S&E Shoulder and Elbow, TJA Total Joint Arthroplasty, TKA Total Knee Arthroplasty [] Numbers in parentheses are the relevant references Fig. 2 Global distribution of institutional and hospital-based (Level II–IV) arthroplasty registries.…”
Purpose
Four joint arthroplasty registries (JARs) levels exist based on the recorded data type. Level I JARs are national registries that record primary data. Hospital or institutional JARs (Level II–IV) document further data (patient-reported outcomes, demographic, radiographic). A worldwide list of Level II–IV JARs must be created to effectively assess and categorize these data.
Methods
Our study is a systematic scoping review that followed the PRISMA guidelines and included 648 studies. Based on their publications, the study aimed to map the existing Level II–IV JARs worldwide. The secondary aim was to record their lifetime, publications’ number and frequency and recognise differences with national JARs.
Results
One hundred five Level II–IV JARs were identified. Forty-eight hospital-based, 45 institutional, and 12 regional JARs. Fifty JARs were found in America, 39 in Europe, nine in Asia, six in Oceania and one in Africa. They have published 485 cohorts, 91 case-series, 49 case–control, nine cross-sectional studies, eight registry protocols and six randomized trials. Most cohort studies were retrospective. Twenty-three per cent of papers studied patient-reported outcomes, 21.45% surgical complications, 13.73% postoperative clinical and 5.25% radiographic outcomes, and 11.88% were survival analyses. Forty-four JARs have published only one paper. Level I JARs primarily publish implant revision risk annual reports, while Level IV JARs collect comprehensive data to conduct retrospective cohort studies.
Conclusions
This is the first study mapping all Level II–IV JARs worldwide. Most JARs are found in Europe and America, reporting on retrospective cohorts, but only a few report on studies systematically.
“…FORI (Shoulder) [ 153 , 182 , 183 , 424 , 526 , 566 , 567 , 604 ] 2. Texas Southwestern University [ 211 , 459 ] Virginia OrthoVirginia [ 287 , 547 ] ABJHI Alberta Bone and Joint Health Institute, CHKR Center for Hip and Knee Replacement Joint Registry, CJRI Connecticut Joint Replacement Institute, CJRR California Joint Replacement Registry, FOI Florida Orthopaedic Institute, Shoulder, FORI Fondren Orthopedic Research Institute, H&K Hip and Knee, HS Hospital, JAR Joint Arthroplasty Registry, JRR Joint Replacement Registry, MARCQI Michigan Collaborative Quality Initiative, NY New York, RG Registry, OJRR Ontario Joint Replacement Registry, PAR Partners Massachusetts Registry, S&E Shoulder and Elbow, TJA Total Joint Arthroplasty, TKA Total Knee Arthroplasty [] Numbers in parentheses are the relevant references Fig. 2 Global distribution of institutional and hospital-based (Level II–IV) arthroplasty registries.…”
Purpose
Four joint arthroplasty registries (JARs) levels exist based on the recorded data type. Level I JARs are national registries that record primary data. Hospital or institutional JARs (Level II–IV) document further data (patient-reported outcomes, demographic, radiographic). A worldwide list of Level II–IV JARs must be created to effectively assess and categorize these data.
Methods
Our study is a systematic scoping review that followed the PRISMA guidelines and included 648 studies. Based on their publications, the study aimed to map the existing Level II–IV JARs worldwide. The secondary aim was to record their lifetime, publications’ number and frequency and recognise differences with national JARs.
Results
One hundred five Level II–IV JARs were identified. Forty-eight hospital-based, 45 institutional, and 12 regional JARs. Fifty JARs were found in America, 39 in Europe, nine in Asia, six in Oceania and one in Africa. They have published 485 cohorts, 91 case-series, 49 case–control, nine cross-sectional studies, eight registry protocols and six randomized trials. Most cohort studies were retrospective. Twenty-three per cent of papers studied patient-reported outcomes, 21.45% surgical complications, 13.73% postoperative clinical and 5.25% radiographic outcomes, and 11.88% were survival analyses. Forty-four JARs have published only one paper. Level I JARs primarily publish implant revision risk annual reports, while Level IV JARs collect comprehensive data to conduct retrospective cohort studies.
Conclusions
This is the first study mapping all Level II–IV JARs worldwide. Most JARs are found in Europe and America, reporting on retrospective cohorts, but only a few report on studies systematically.
“…Additionally, tobacco use has established consequences on wound healing and has been associated with wound healing issues following DA THA [ 34 ]. Increasing age also has known impacts on wound healing ability, although the effect of age on wound healing in the THA population, specifically, remains poorly studied [ 35 ].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
